Search

everythinglearnresearchcommunity

for

Search:↓

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Laser treatment and deroofing are effective options for hidradenitis suppurativa.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

The 5% minoxidil lotion without propylene glycol is effective, well-tolerated, and cosmetically acceptable for hair loss.

Dutasteride is more effective than finasteride for long-term hair growth in men with androgenic alopecia.

Bupropion may help treat trichotillomania when fluoxetine doesn't work.

Baricitinib is effective for severe alopecia areata but has some side effects.

Light/laser therapy can effectively increase hair density in some types of alopecia, especially androgenic alopecia and alopecia areata.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Suppressing certain hormones might help prevent prostate cancer.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Low-dose oral minoxidil combined with topical minoxidil improves hair growth in breast cancer patients with therapy-induced hair loss.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

Juvéderm fillers effectively reduce wrinkles for up to 21 months with less filler needed for repeat treatments.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

An emollient PLUS balm with ADE-G1 significantly improved skin dryness and quality of life in cancer patients with xerosis.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.